Cardio Diagnostics Holdings Stock Performance
| CDIO Stock | USD 0.43 0.02 4.44% |
The firm shows a Beta (market volatility) of 2.61, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardio Diagnostics will likely underperform. At this point, Cardio Diagnostics has a negative expected return of -0.92%. Please make sure to confirm Cardio Diagnostics' potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Cardio Diagnostics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Acquisition by Intrater James of 4544 shares of Cardio Diagnostics at 0.92 subject to Rule 16b-3 | 12/31/2024 |
2 | Acquisition by Hosseinion Warren of 123750 shares of Cardio Diagnostics at 1.26 subject to Rule 16b-3 | 01/10/2025 |
3 | Acquisition by Meeshanthini Dogan of 272250 shares of Cardio Diagnostics at 1.26 subject to Rule 16b-3 | 01/13/2025 |
4 | Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations | 02/04/2025 |
5 | Cardio Diagnostics plans 50M mixed shelf offering | 02/07/2025 |
6 | Acquisition by Lau Stanley K. of 21008 shares of Cardio Diagnostics at 1.19 subject to Rule 16b-3 | 03/14/2025 |
7 | Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD, Actionable Clinical Intelligence and New Clinical Advancements at the American College of C... | 03/26/2025 |
| Begin Period Cash Flow | 1.3 M |
Cardio |
Cardio Diagnostics Relative Risk vs. Return Landscape
If you would invest 93.00 in Cardio Diagnostics Holdings on December 27, 2024 and sell it today you would lose (50.00) from holding Cardio Diagnostics Holdings or give up 53.76% of portfolio value over 90 days. Cardio Diagnostics Holdings is currently does not generate positive expected returns and assumes 8.6492% risk (volatility on return distribution) over the 90 days horizon. In different words, 77% of stocks are less volatile than Cardio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cardio Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardio Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cardio Diagnostics Holdings, and traders can use it to determine the average amount a Cardio Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CDIO |
Estimated Market Risk
| 8.65 actual daily | 77 77% of assets are less volatile |
Expected Return
| -0.92 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cardio Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardio Diagnostics by adding Cardio Diagnostics to a well-diversified portfolio.
Cardio Diagnostics Fundamentals Growth
Cardio Stock prices reflect investors' perceptions of the future prospects and financial health of Cardio Diagnostics, and Cardio Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardio Stock performance.
| Return On Equity | -1.34 | ||||
| Return On Asset | -0.69 | ||||
| Operating Margin | (336.08) % | ||||
| Current Valuation | 15.42 M | ||||
| Shares Outstanding | 52.15 M | ||||
| Price To Book | 2.36 X | ||||
| Price To Sales | 647.30 X | ||||
| Revenue | 2.02 K | ||||
| Gross Profit | 34.89 K | ||||
| EBITDA | (8.09 M) | ||||
| Net Income | (8.38 M) | ||||
| Cash And Equivalents | 9.66 M | ||||
| Cash Per Share | 5.08 X | ||||
| Total Debt | 663.1 K | ||||
| Current Ratio | 18.42 X | ||||
| Book Value Per Share | 0.21 X | ||||
| Cash Flow From Operations | (4.99 M) | ||||
| Earnings Per Share | (0.31) X | ||||
| Market Capitalization | 22.58 M | ||||
| Total Asset | 10.62 M | ||||
| Retained Earnings | (22.75 M) | ||||
| Working Capital | 8.16 M | ||||
About Cardio Diagnostics Performance
By examining Cardio Diagnostics' fundamental ratios, stakeholders can obtain critical insights into Cardio Diagnostics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cardio Diagnostics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.79) | (0.83) | |
| Return On Capital Employed | (0.84) | (0.88) | |
| Return On Assets | (0.79) | (0.83) | |
| Return On Equity | (0.88) | (0.92) |
Things to note about Cardio Diagnostics performance evaluation
Checking the ongoing alerts about Cardio Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardio Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cardio Diagnostics generated a negative expected return over the last 90 days | |
| Cardio Diagnostics has high historical volatility and very poor performance | |
| Cardio Diagnostics has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 2.02 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 34.89 K. | |
| Cardio Diagnostics Holdings currently holds about 9.66 M in cash with (4.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardio Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD, Actionable Clinical Intelligence and New Clinical Advancements at the American College of Cardiologys 74th Annual Scientific Session |
- Analyzing Cardio Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardio Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Cardio Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cardio Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardio Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cardio Diagnostics' stock. These opinions can provide insight into Cardio Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.31) | Revenue Per Share | Quarterly Revenue Growth (0.15) | Return On Assets | Return On Equity |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.